|
Jul 28
|
Tempus AI or NVIDIA: Which is the Smarter Bet in AI-Backed Healthcare?
|
|
Jul 28
|
Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.
|
|
Jul 28
|
European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading
|
|
Jul 28
|
15 regions chosen for groundbreaking effort to reduce cardiovascular disease
|
|
Jul 28
|
3 Surprisingly Underrated Stocks to Buy Right Now
|
|
Jul 28
|
Novo Nordisk faces 'show me' moment to boost Wegovy growth after US copycat ban
|
|
Jul 28
|
Kepler Capital Remains Bullish on Novo Nordisk A/S (NVO)
|
|
Jul 27
|
The Patients Forced to Switch From Zepbound to Wegovy
|
|
Jul 27
|
Leerink Partners and Jefferies Issue Bullish Ratings on Eli Lilly and Company (LLY)
|
|
Jul 27
|
2 Healthcare Stocks That Are Losing to the S&P 500 This Year
|
|
Jul 25
|
Novo Nordisk A/S (NVO) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Jul 25
|
European regulatory authority adopts positive opinion for Novo Nordisk’s Alhemo® (concizumab), recommending label expansion to treat haemophilia A and B without inhibitors
|
|
Jul 25
|
Exclusive-China's Sciwind is in talks to license weight-loss drug in US, CEO says
|
|
Jul 24
|
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Thursday Trading
|
|
Jul 24
|
This Weight-Loss Stock Sank After Earnings. It’s Still a Risk for Eli Lilly, Novo Nordisk.
|
|
Jul 24
|
Novo Nordisk (NVO) is a Top-Ranked Momentum Stock: Should You Buy?
|
|
Jul 24
|
West Pharma soars on profit forecast raise, lowered tariff impact estimate
|
|
Jul 24
|
Novo Nordisk defeated in Wegovy patent dispute by Viatris
|
|
Jul 24
|
Coagulation Factor Deficiency Market Research Report 2025 | Advancements in Long-Acting Clotting Factors and Gene Therapies Propel Growth - Global Forecast to 2035
|
|
Jul 23
|
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
|